Clinical trial
SGN-00101 Vaccine in Treating Human Papillomavirus in Patients Who Have Abnormal…
NCT00091130 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00091130 |
|---|---|
| Title | SGN-00101 Vaccine in Treating Human Papillomavirus in Patients Who Have Abnormal Cervical Cells |
| Official title | An Exploratory Study to Evaluate the Effect of HPV 16 Vaccine on the Reduction of Viral Load in HPV 16 Positive Women With Persistent Viral Infection, But Low Grade Disease (ASCUS/LSIL) |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Atypical Squamous Cells of Undetermined Significance, Cervical Cancer, High-grade Squamous Intraepithelial Lesion, Low-grade Squamous Intraepithelial Lesion |
| Intervention type | Biological, Other |
| Interventions | HspE7, placebo, laboratory biomarker analysis |
| Enrollment | 139 |
| Start date | Sep 1, 2004 |
| Primary completion | Jun 1, 2007 |
| First posted | Sep 8, 2004 |
| Last update posted | Jun 3, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: